Bartlett & Co. Wealth Management LLC Nektar Therapeutics Transaction History

Bartlett & Co. Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2024	SELL	$2.03 - $4.28 $202 - $428	-100 Closed	0 $0
Q1 2022 Feb 14, 2024	BUY	$4.16 - $13.72 $416 - $1,372	100 New	100 $539,000
Q3 2021 Feb 13, 2024	SELL	$13.07 - $18.84 $26 - $37	-2 Closed	0 $0
Q4 2020 Feb 13, 2024	BUY	$15.77 - $19.03 $31 - $38	2 New	2 $34,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Bartlett & Co. Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bartlett & Co. Wealth Management LLC with notifications on news.